ONCSQ (OncoSec Medical) Total Stockholders Equity: $-5.49 Mil (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoSec Medical Total Stockholders Equity?

OncoSec Medical ONCSQ -99.00% Total Stockholders Equity is $-5.49 Mil as of Jan. 2023.

OncoSec Medical's Total Stockholders Equity for the quarter that ended in Jan. 2023 was $-5.49 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. OncoSec Medical's Book Value per Share for the quarter that ended in Jan. 2023 was $-1.85. The ratio of a company's debt over equity can be used to measure how leveraged this company is. OncoSec Medical's Debt-to-Equity for the quarter that ended in Jan. 2023 was -0.63.

OncoSec Medical  (OTCPK:ONCSQ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

OncoSec Medical's Book Value per Share for the quarter that ended in Jan. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-5.486-0)/2.971
=-1.85

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

OncoSec Medical's Debt-to-Equity for the quarter that ended in Jan. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.338 + 2.127) / -5.486
=-0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Total Stockholders Equity Related Terms

OncoSec Medical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Total Stockholders Equity Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.92 24.28 13.87 38.08 6.12

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.82 13.89 6.12 -0.98 -5.49
What does a Total Stockholders Equity of $-5.49 Mil mean?
OncoSec Medical (ONCSQ) has a Total Stockholders Equity of $-5.49 Mil as of Jan. 2023. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for OncoSec Medical and its competitors.
Is OncoSec Medical's Total Stockholders Equity too high?
OncoSec Medical's current Total Stockholders Equity is $-5.49 Mil.
How does OncoSec Medical's Total Stockholders Equity compare to NOVNQ and USRM?
OncoSec Medical's Total Stockholders Equity of $-5.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for OncoSec Medical and its competitors. OncoSec Medical's current Total Stockholders Equity is $-5.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Total Stockholders Equity of $-5.49 Mil. The current Total Stockholders Equity is $-5.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Total Stockholders Equity is $-5.49 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.